FTRE - Fortrea Holdings Inc.
About Fortrea Holdings Inc. (https://www.fortrea.com)
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Anshul Thakral | Chief Executive Officer & Director | 1978 | $1,686,897 USD |
| Jill McConnell | Chief Financial Officer | 1975 | $817,879 USD |
| Mark A. Morais | Chief Operating Officer & President of Clinical Services | 1977 | $812,667 USD |
| Agnieszka Gallagher | General Counsel & Corporate Secretary | 1974 | – |
| Alejandro Martinez Galindo | Chief Information Officer | – | – |
| Dave Cooper | Chief Administrative Officer | – | – |
| Drayton Virkler | President & Chief Commercial Officer | – | – |
| Hima Inguva | Head of Corporate Development | – | – |
| Leonard Scott Dove | President of Clinical Pharmacology Services | 1974 | – |
| Oren J. Cohen | Chief Medical Officer | 1961 | – |
| Robert Parks | Chief Accounting Officer | – | – |
| Sandy Kennedy | Chief Quality, Regulatory Affairs & Sustainability Officer | – | – |
| Tracy H. Krumme | Senior Vice President of Investor Relations | 1968 | – |